nitroglycerin has been researched along with Pancreatitis in 30 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prophylactic pancreatic stent placement (PSP) and rectal indomethacin suppository are recommended to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk cases." | 9.34 | Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients. ( Li, G; Lin, J; Qiu, W; Sun, D; Wang, Y; Xu, B; Zhang, W, 2020) |
| " This study aimed to investigate the potential impact of nitroglycerin and glucagon administration on selective CBD cannulation and prevention of post-ERCP pancreatitis." | 9.24 | Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis. ( Anastasiadou, K; Chatzimavroudis, G; Gatopoulou, A; Georgakis, N; Katsinelos, P; Katsinelos, T; Kountouras, J; Lazaraki, G; Psarras, K; Zeglinas, C, 2017) |
| "To evaluate the efficacy of valdecoxib, a cyclo-oxygenase-2 inhibitor, and GTN transdermal patch for the prevention of post-ERCP pancreatitis." | 9.15 | A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. ( Acharya, SK; Ahuja, V; Bhatia, V; Garg, PK, 2011) |
| "Several studies have suggested that nitroglycerin promotes pancreatic drainage and thereby helps to prevent pancreatitis occurring after endoscopic retrograde cholangiography (ERC)." | 9.13 | Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. ( Barrioz, T; Barthet, M; Beauchant, M; Capony, P; Dupuychaffray, JP; Escourrou, J; Favriel, JM; Ingrand, I; Ingrand, P; Lacoste, L; Moindrot, H; Plane, C, 2008) |
| "The objective of this research paper is to evaluate the effect of prophylactic nitroglycerin in the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) by performing a meta-analysis of randomized controlled trials (RCTs)." | 8.86 | Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. ( Cai, JT; Chen, MY; Chen, QY; Shao, LM, 2010) |
| "To evaluate the preventive effect of nitroglycerin on post-ERCP pancreatitis by a meta-analysis of randomized clinical studies." | 8.85 | Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis. ( Andersen, PK; Bang, UC; Matzen, P; Nøjgaard, C, 2009) |
| " The authors describe their clinical practice during the last 15 years: nitrates with short half-life in the treatment of acute pancreatitis (amylnitrit or nitroglycerin spray) which have a low risk of developing nitrate tolerance; chronic administration of retard nitroglycerin in chronic pancreatitis and Oddi's sphincter hypertonic dyskinesia." | 8.78 | The role of nitroglycerin preparations in the treatment of post-acute and chronic pancreatitis. ( Berger, Z; Pap, A, 1993) |
| "Prophylactic pancreatic stent placement (PSP) and rectal indomethacin suppository are recommended to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk cases." | 5.34 | Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients. ( Li, G; Lin, J; Qiu, W; Sun, D; Wang, Y; Xu, B; Zhang, W, 2020) |
| " This study aimed to investigate the potential impact of nitroglycerin and glucagon administration on selective CBD cannulation and prevention of post-ERCP pancreatitis." | 5.24 | Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis. ( Anastasiadou, K; Chatzimavroudis, G; Gatopoulou, A; Georgakis, N; Katsinelos, P; Katsinelos, T; Kountouras, J; Lazaraki, G; Psarras, K; Zeglinas, C, 2017) |
| "We carried out a literature search of random controlled trials (RCTs) on preventing post-operative pancreatitis by administration of the anti-inflammatory drugs, indomethacin and diclofenac, following endoscopic retrograde cholangiopancreatography (ERCP)." | 5.22 | Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis. ( Du, F; Fan, H; Ren, L; Yang, X; Yuan, W; Zhang, L; Zhang, Y, 2022) |
| "To evaluate the efficacy of valdecoxib, a cyclo-oxygenase-2 inhibitor, and GTN transdermal patch for the prevention of post-ERCP pancreatitis." | 5.15 | A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. ( Acharya, SK; Ahuja, V; Bhatia, V; Garg, PK, 2011) |
| "Several studies have suggested that nitroglycerin promotes pancreatic drainage and thereby helps to prevent pancreatitis occurring after endoscopic retrograde cholangiography (ERC)." | 5.13 | Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. ( Barrioz, T; Barthet, M; Beauchant, M; Capony, P; Dupuychaffray, JP; Escourrou, J; Favriel, JM; Ingrand, I; Ingrand, P; Lacoste, L; Moindrot, H; Plane, C, 2008) |
| "The objective of this research paper is to evaluate the effect of prophylactic nitroglycerin in the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) by performing a meta-analysis of randomized controlled trials (RCTs)." | 4.86 | Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. ( Cai, JT; Chen, MY; Chen, QY; Shao, LM, 2010) |
| "To evaluate the preventive effect of nitroglycerin on post-ERCP pancreatitis by a meta-analysis of randomized clinical studies." | 4.85 | Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis. ( Andersen, PK; Bang, UC; Matzen, P; Nøjgaard, C, 2009) |
| "Although trials evaluating the preventive effect of glyceryl trinitrate (GTN; nitroglycerin) on pancreatitis occurring after endoscopic retrograde cholangiopancreatography (ERCP) have been reported, there is no agreement as to whether prophylactic GTN treatment can in fact reduce the incidence of post-ERCP pancreatitis." | 4.85 | Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials. ( Bai, Y; Gao, J; Li, ZS; Xu, C; Yang, X; Zou, DW, 2009) |
| " The authors describe their clinical practice during the last 15 years: nitrates with short half-life in the treatment of acute pancreatitis (amylnitrit or nitroglycerin spray) which have a low risk of developing nitrate tolerance; chronic administration of retard nitroglycerin in chronic pancreatitis and Oddi's sphincter hypertonic dyskinesia." | 4.78 | The role of nitroglycerin preparations in the treatment of post-acute and chronic pancreatitis. ( Berger, Z; Pap, A, 1993) |
| "The aim of the study was to investigate the use of prophylactic nitroglycerin patch in patients who applied to our clinic with occlusion icter and underwent endoscopic retrograde cholangiopancreatography (ERCP) for complications such as pancreatitis, bleeding, perforation that may occur during and after the procedure, duration of the procedure, length of hospitalization, precut and selective cannulation rates, and mortality." | 4.31 | The effect of using nitroderm TTS in ERCP on precut, selective cannulation, and bleeding. ( Calta, AF; Duran, A, 2023) |
| "Acute pancreatitis is the most common complication of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP)." | 2.49 | Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials. ( Ding, J; Jin, X; Li, Y; Liu, S; Pan, Y, 2013) |
| "Nitroglycerin (NGL) is a nitrogen oxide (NO) donor, which relaxes the sphincter of Oddi." | 2.44 | Pharmacological approach to acute pancreatitis. ( Bang, UC; Bendtsen, F; Nojgaard, C; Semb, S, 2008) |
| "Nitroglycerin 0." | 1.30 | Endoscopic lithotomy of common bile duct stones with sublingual nitroglycerin and guidewire. ( Ezaki, T; Fukuma, H; Hirabayashi, S; Kurokohchi, K; Matsuoka, H; Matsuoka, M; Minami, A; Morshed, SA; Nakatsu, T; Nishioka, M; Uchida, N; Yachida, M, 1997) |
| "Acute pancreatitis was induced in rats by a supramaximal dose of caerulein." | 1.30 | The role of nitric oxide in caerulein-induced acute pancreatitis and the recovery process after inflammatory damage. ( Dzieciol, J; Gabryelewicz, A; Jurkowska, G; Rydzewska, G, 1999) |
| "This study used an animal model of acute pancreatitis induced by intravenous caeruleint (10 micrograms/kg/h for up to six hours), which does not entail either haemorrhage or significant necrosis of the pancreas." | 1.29 | Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis. ( Adler, G; Gress, TM; Lerch, MM; Pfaff, D; Turi, S; Weidenbach, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 14 (46.67) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, F | 1 |
| Zhang, Y | 1 |
| Yang, X | 2 |
| Zhang, L | 1 |
| Yuan, W | 1 |
| Fan, H | 1 |
| Ren, L | 1 |
| Calta, AF | 1 |
| Duran, A | 1 |
| Wang, Y | 3 |
| Xu, B | 1 |
| Zhang, W | 1 |
| Lin, J | 1 |
| Li, G | 1 |
| Qiu, W | 1 |
| Sun, D | 1 |
| Ding, J | 1 |
| Jin, X | 1 |
| Pan, Y | 1 |
| Liu, S | 1 |
| Li, Y | 1 |
| Dumonceau, JM | 1 |
| Andriulli, A | 1 |
| Elmunzer, BJ | 1 |
| Mariani, A | 1 |
| Meister, T | 1 |
| Deviere, J | 1 |
| Marek, T | 1 |
| Baron, TH | 1 |
| Hassan, C | 1 |
| Testoni, PA | 1 |
| Kapral, C | 1 |
| Katsinelos, P | 1 |
| Lazaraki, G | 1 |
| Chatzimavroudis, G | 1 |
| Katsinelos, T | 1 |
| Georgakis, N | 1 |
| Anastasiadou, K | 1 |
| Gatopoulou, A | 1 |
| Zeglinas, C | 1 |
| Psarras, K | 1 |
| Kountouras, J | 1 |
| Beauchant, M | 1 |
| Ingrand, P | 1 |
| Favriel, JM | 1 |
| Dupuychaffray, JP | 1 |
| Capony, P | 1 |
| Moindrot, H | 1 |
| Barthet, M | 1 |
| Escourrou, J | 1 |
| Plane, C | 1 |
| Barrioz, T | 1 |
| Lacoste, L | 1 |
| Ingrand, I | 1 |
| Hao, JY | 1 |
| Wu, DF | 1 |
| Wang, YZ | 1 |
| Gao, YX | 1 |
| Lang, HP | 1 |
| Zhou, WZ | 1 |
| Shao, LM | 1 |
| Chen, QY | 1 |
| Chen, MY | 1 |
| Cai, JT | 1 |
| Bang, UC | 2 |
| Nøjgaard, C | 1 |
| Andersen, PK | 1 |
| Matzen, P | 1 |
| Bai, Y | 1 |
| Xu, C | 1 |
| Gao, J | 1 |
| Zou, DW | 1 |
| Li, ZS | 1 |
| Chen, B | 1 |
| Fan, T | 1 |
| Wang, CH | 1 |
| Bhatia, V | 1 |
| Ahuja, V | 1 |
| Acharya, SK | 1 |
| Garg, PK | 1 |
| Moretó, M | 2 |
| Zaballa, M | 2 |
| Casado, I | 1 |
| Merino, O | 1 |
| Rueda, M | 1 |
| Ramírez, K | 1 |
| Urcelay, R | 1 |
| Baranda, A | 1 |
| Andrzejewska, A | 1 |
| Jurkowska, G | 2 |
| Augustynowicz, A | 1 |
| Cheema, AW | 1 |
| Leya, J | 1 |
| Muralidharan, V | 1 |
| Jamidar, P | 1 |
| Kaffes, AJ | 1 |
| Bourke, MJ | 1 |
| Ding, S | 1 |
| Alrubaie, A | 1 |
| Kwan, V | 1 |
| Williams, SJ | 1 |
| DiMagno, MJ | 1 |
| Semb, S | 1 |
| Nojgaard, C | 1 |
| Bendtsen, F | 1 |
| Weidenbach, H | 1 |
| Lerch, MM | 1 |
| Gress, TM | 1 |
| Pfaff, D | 1 |
| Turi, S | 1 |
| Adler, G | 1 |
| Berger, Z | 1 |
| Pap, A | 1 |
| Christensen, MH | 1 |
| Schulze, S | 1 |
| Rosenberg, J | 1 |
| Uchida, N | 1 |
| Ezaki, T | 1 |
| Hirabayashi, S | 1 |
| Minami, A | 1 |
| Fukuma, H | 1 |
| Matsuoka, H | 1 |
| Yachida, M | 1 |
| Kurokohchi, K | 1 |
| Morshed, SA | 1 |
| Nishioka, M | 1 |
| Matsuoka, M | 1 |
| Nakatsu, T | 1 |
| Rydzewska, G | 1 |
| Gabryelewicz, A | 1 |
| Dzieciol, J | 1 |
| Sudhindran, S | 1 |
| Bromwich, E | 1 |
| Edwards, PR | 1 |
| Harinath, G | 1 |
| O'Riordan, B | 1 |
| Shcherbiuk, AN | 1 |
| Ivanov, PA | 1 |
| Grishin, AV | 1 |
| Luk'ianova, KB | 1 |
| Kudriaev, IG | 1 |
| Miroshenkova, EIu | 1 |
| White, TT | 1 |
| Bourde, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate to Prevent Post-ERCP Pancreatitis: a Multicentre, Non-inferiority, Double-blind, Randomised Trial[NCT04425993] | 2,700 participants (Actual) | Interventional | 2020-07-01 | Active, not recruiting | |||
| Endoscopic Retrograde Cholangiopancreatography (ERCP)-Induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?[NCT02602574] | 66 participants (Anticipated) | Observational | 2018-01-31 | Enrolling by invitation | |||
| Is Needle Knife Fistulotomy An Effective First Step Strategy For All ERCPs?[NCT03698266] | 84 participants (Actual) | Interventional | 2018-11-23 | Completed | |||
| Comparative Evaluation of Standard Prophylaxis Versus Divided-dose NSAIDs or Hybrid NSAID and N-acetylcysteine Therapy for the Prevention of Post-ERCP Pancreatitis[NCT03708458] | Phase 4 | 250 participants (Anticipated) | Interventional | 2017-04-01 | Recruiting | ||
| Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing Post-ERCP Pancreatitis in Patients With Difficult Cannulation[NCT04340687] | 664 participants (Actual) | Observational | 2020-01-01 | Completed | |||
| Risk Factors Related to Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-risk Patients Who Underwent ERCP and Received Prophylactic Rectal Indomethacin[NCT02709421] | 790 participants (Actual) | Observational | 2016-02-29 | Completed | |||
| Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin: A Multi-center, Double-blind, Randomized Controlled Trial[NCT03057769] | 3,300 participants (Actual) | Interventional | 2017-02-01 | Terminated (stopped due to This study was terminated because of an interim analysis suggesting futility of papillary epinephrine spraying in PEP prevention.) | |||
| [NCT00121901] | Phase 3 | 1,600 participants (Anticipated) | Interventional | 2004-10-31 | Completed | ||
| Effect of Transdermal Glyceryl-Trinitrate and Parecoxib (Valdecoxib) for the Prevention of Post -ERCP Pancreatitis[NCT00419549] | Phase 2/Phase 3 | 371 participants (Actual) | Interventional | 2003-10-31 | Terminated (stopped due to Because one of the drugs Valdecoxib was withdrawn due to safety concerns.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for nitroglycerin and Pancreatitis
| Article | Year |
|---|---|
Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2022 |
Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials.
Topics: Catheterization; Cholangiopancreatography, Endoscopic Retrograde; Humans; Nitroglycerin; Pancreatiti | 2013 |
Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis.
Topics: Cholangiopancreatography, Endoscopic Retrograde; Humans; Nitroglycerin; Pancreatitis; Randomized Con | 2010 |
Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis.
Topics: Anti-Inflammatory Agents; Cholangiopancreatography, Endoscopic Retrograde; Humans; Nitroglycerin; Pa | 2009 |
Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Topics: Cholangiopancreatography, Endoscopic Retrograde; Confidence Intervals; Humans; Incidence; Nitroglyce | 2009 |
A meta-analysis for the effect of prophylactic GTN on the incidence of post-ERCP pancreatitis and on the successful rate of cannulation of bile ducts.
Topics: Bile Ducts; Catheterization; Cholangiopancreatography, Endoscopic Retrograde; Humans; Incidence; Nit | 2010 |
Pharmacological approach to acute pancreatitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, No | 2008 |
The role of nitroglycerin preparations in the treatment of post-acute and chronic pancreatitis.
Topics: Acute Disease; Ampulla of Vater; Blood Glucose; Calcium Channel Blockers; Cholecystokinin; Chronic D | 1993 |
8 trials available for nitroglycerin and Pancreatitis
| Article | Year |
|---|---|
Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Female; Hu | 2020 |
Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis.
Topics: Aged; Aged, 80 and over; Catheterization; Cholangiopancreatography, Endoscopic Retrograde; Common Bi | 2017 |
Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
Topics: Abdominal Pain; Adult; Aged; Amylases; Biomarkers; Chi-Square Distribution; Cholangiopancreatography | 2008 |
Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial.
Topics: Adult; Aged; Cholangiopancreatography, Endoscopic Retrograde; Female; Humans; Hyperamylasemia; Male; | 2009 |
A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Endoscopic Retrograde; Cycloox | 2011 |
Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.
Topics: Administration, Cutaneous; Aged; Amylases; Cholangiopancreatography, Endoscopic Retrograde; Double-B | 2003 |
Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.
Topics: Administration, Cutaneous; Aged; Amylases; Cholangiopancreatography, Endoscopic Retrograde; Double-B | 2003 |
Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.
Topics: Administration, Cutaneous; Aged; Amylases; Cholangiopancreatography, Endoscopic Retrograde; Double-B | 2003 |
Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.
Topics: Administration, Cutaneous; Aged; Amylases; Cholangiopancreatography, Endoscopic Retrograde; Double-B | 2003 |
A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Catheterization; Cholangiopancreatography, Endos | 2006 |
Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Endoscopic Retrograde; Doub | 2001 |
14 other studies available for nitroglycerin and Pancreatitis
| Article | Year |
|---|---|
The effect of using nitroderm TTS in ERCP on precut, selective cannulation, and bleeding.
Topics: Catheterization; Cholangiopancreatography, Endoscopic Retrograde; Hemorrhage; Humans; Nitroglycerin; | 2023 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopi | 2014 |
The influence of nitric oxide synthesis modulation on the pancreatic acinar cells in caerulein-induced acute pancreatitis. An ultrastructural and morphometric study.
Topics: Animals; Arginine; Ceruletide; Enzyme Inhibitors; Enzyme Precursors; Male; Microscopy, Electron; Mit | 2002 |
Validity of using standard error of mean in trials.
Topics: Cholangiopancreatography, Endoscopic Retrograde; Humans; Nitroglycerin; Pancreatitis; Statistics as | 2003 |
Pharmacologic prevention of post-ERCP pancreatitis: is nitroglycerin a sangreal?
Topics: Catheterization; Cholangiopancreatography, Endoscopic Retrograde; Humans; Nitroglycerin; Pancreatiti | 2006 |
Nitric oxide pathways and evidence-based perturbations in acute pancreatitis.
Topics: Acute Disease; Aged; Animals; Cholangiopancreatography, Endoscopic Retrograde; Female; Humans; Male; | 2007 |
Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis.
Topics: Acute Disease; Animals; Arginine; Bradykinin; Catecholamines; Ceruletide; Edema; Labetalol; Male; Mi | 1995 |
[Effect of sublingual nitroglycerin on pain following ERCP].
Topics: Administration, Sublingual; Analgesics; Cholangiopancreatography, Endoscopic Retrograde; Female; Hum | 1997 |
Endoscopic lithotomy of common bile duct stones with sublingual nitroglycerin and guidewire.
Topics: Acute Disease; Administration, Sublingual; Adult; Aged; Aged, 80 and over; Amylases; Blood Pressure; | 1997 |
The role of nitric oxide in caerulein-induced acute pancreatitis and the recovery process after inflammatory damage.
Topics: Acute Disease; Animals; Arginine; Ceruletide; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroglycer | 1999 |
Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopacreatography-induced pancreatitis (Br J Surg 2001;88:1178-82).
Topics: Cholangiopancreatography, Endoscopic Retrograde; Double-Blind Method; Humans; Nitroglycerin; Pancrea | 2002 |
Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
Topics: Cholangiopancreatography, Endoscopic Retrograde; Double-Blind Method; Humans; Nitroglycerin; Pancrea | 2002 |
[The correction of the hemodynamic disorders in acute pancreatitis patients by intravenous nitroglycerin infusions].
Topics: Acute Disease; Adult; Aged; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Nitroglycerin | 1991 |
A new observation on human intraductal pancreatic pressure.
Topics: Bethanechol Compounds; Catheterization; Cholecystokinin; Contrast Media; Humans; Injections, Intrave | 1970 |